Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response.
Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK.
Merrick VM, et al. Among authors: mitton sg.
J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):274-280. doi: 10.1097/MPG.0000000000001679.
J Pediatr Gastroenterol Nutr. 2018.
PMID: 29356768